UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect
The UK’s first fully-licensed EU-GMP medical cannabis cultivation facility has opened its doors to doctors,
Since the legalisation of medical cannabis in the UK in 2018, its integration into mainstream
Written by: Releaf’s Clinical Dr Alex Van Heerden After years prescribing opioids, Dr Alexander Van
Researchers from Brazil have published a detailed study showing significant improvements in a patient living
A recent YouGov poll, asking the British public their views on cannabis reform compared to
At PatientsCann UK, we are deeply concerned by Network Rail’s recently issued safety advice (NRA24-13), which imposes a blanket ban
The post Network Rail’s Medical Cannabis Policy: A Cause for Concern first appeared on PatientsCann UK.
Via Business of Cannabis In a long-awaited and major step forward for the UK’s CBD
The legal dispensing of cannabis via a cultivation association has taken place for the first
Six years on from the legalisation of medical cannabis in the UK, families have made
A message from Dr Simon Erridge, Research Director at Curaleaf Clinic At Curaleaf Clinic, we’re
A study has found that a single high dose of psilocybin can lead to physical
Berlin, Germany – 16 October, 2024 – Following the adoption of the CanG and the
The number of items prescribed in the UK’s private medical cannabis market has doubled each
Product Earth, the UK’s largest event celebrating cannabis and other natural medicines, has cancelled the
Landlords, property managers, and housing associations in the UK are currently at risk of breaching
Written by Releaf Releaf offers every patient at the clinic a medical cannabis card to
Introduction: The Life of a CAPEX Director As the Director of Capital Projects (CAPEX) for investors based in Geneva, my professional journey took me to Africa, South Asia, and the Middle East. My work involved extensive travel to various “hot spots,” which left me returning home to England only when possible. This lifestyle eventually took […]
The post From CAPEX Director to Cannabis Advocate: A Journey of Resilience and Healing appeared first on I Am Billy.
In what was thought to be a first for a major mainstream health conference on
A new animal study has highlighted the possible benefits of CBD and the diabetes drug,
Despite the popularity of cannabidiol (CBD) infused edibles among consumers there are storm clouds on the horizon for this market. The potential threat stems from continuing uncertainty about the regulatory status of CBD in the United States (US) and the European Union (EU). Recent statements by
In an extract from the handbook, Principles of Clinical Cannabinology, Viola Brugnatelli and Fabio Turco explore the cutaneous Endocannabinoid System and its potential applications in treating various dermatological conditions. The skin, the body’s largest organ, serves not only as a protective barrier but also plays crucial
Parkinson’s disease affects 145,000 in the UK. While there are currently no treatments that can slow the progression of the disease, two new studies have investigated if CBD may help. Parkinson’s disease (PD) is a long-term neurological condition. It is progressive and symptoms get worse over
In the rapidly evolving cannabis industry, in both new and emerging markets, securing a cannabis license is an essential step to establishing a successful business. However, navigating the application process can be complex, challenging and highly competitive. To help aspiring entrepreneurs and investors in this burgeoning
The legalisation of cannabis in the US, and subsequent rise in sales, have not contributed to an increase in substance misuse among adolescents, a new study has found. Researchers from Boston College have used the most recent data on adolescent substance use to evaluate the effect
SNP councillor, Laura Brennan-Whitefield, recently spoke about being prescribed medical cannabis for her MS. She tells us why she continues to fight for NHS access. Laura Brennan-Whitefield, a Scottish National Party councillor for the Ayr North ward in south west Scotland, says she was very ‘lucky’
Results produced by a study that analysed data from 600,000 Spanish residents who regularly consumed cannabis indicate that long-term cannabis use does not contribute to the deterioration of health. Using indicators that were specifically designed to give an accurate picture of health, researchers analysed survey responses
A quarter of cannabis consumers are doing so to relieve pain, according to the results of an online poll conducted by US medical cannabis company Nugg MD. 23% said they use weed to deal with symptoms of anxiety, and 18% used it to deal with stress.
The government has this week released plans to make illegal the possession, supply and production of laughing gas, otherwise known as nitrous oxide. The gas, which is commonly used in medical practice and catering, will become a Class C drug. The new ruling means those caught
A survey by Health Canada, the government body responsible for regulating the Canadian cannabis market, has shown that the number of people buying cannabis from illegal sources has dropped to just 3%. The annual Canadian Cannabis Survey aims to give researchers important information about the way
Patients who are living with hypermobility disorders report significant improvements in pain management, sleep quality, and anxiety levels after using cannabis-based medicinal products (CBMPs), according to new research published in the journal ACR Open Rheumatology. Researchers from Imperial College London and the Curaleaf Clinic analysed data
Mandrake. Perhaps you know it by some of its other names: Satan’s apple, Devil’s testicle, Circe’s plant. Or perhaps you thought it was just some fictional plant straight out of Harry Potter or some type of witches’ brew. You wouldn’t be too wrong about the last
Cannabis products and medicines are progressing rapidly, eating away at the market share of smokable flower. Currently, the general adult use cannabis market is split in three, in order of popularity: cannabis flower, vaporizers and ingestible products like edibles or capsules. In the medical market, flower
Once again, the U.S. Food and Drug Administration (FDA) has issued a number of warning letters to companies selling hemp-derived cannabidiol (CBD) products. This time around, the FDA sent these warning letters to companies that had statements on their website claiming CBD is an effective treatment
A recent study published in the journal Psychiatry Research shows no link between prolonged recreational cannabis use and psychosis, even in a cohort of adolescents deemed to be at high risk of developing the disorder. Scientists affiliated with Hofstra University in New York and with Stanford
Network Rail’s policy breaches the Equality Act 2010. PatientsCann UK fights for fair treatment—take action now.
The post Network Rail’s Response to Our Concerns: A Call for Fair and Transparent Policy first appeared on PatientsCann UK.
A study published in the journal Social Psychological and Personality Science has found that chronic cannabis users are motivated and exhibit willingness to carry out tasks that require effort, contrary to the stereotype that stoners are lazy. The study queried 260 cannabis consumers five times per
The trial is described as a ‘key milestone’ in research examining therapeutic alternatives for opioid use disorder. It is hoped the study will help to reverse the effects of the ongoing opioid epidemic. The US-based research-focused biotech company, Ananda Scientific announced its CBD drug will be part
Dravet Syndrome is a rare childhood epilepsy syndrome that is commonly associated with treatment-resistant epilepsy, despite best medical treatment. It is estimated that one in 15,700 children will be diagnosed with the condition, most of which will experience seizures in their first year of life. The
Today marks 5 years since medical cannabis was rescheduled in the UK, making it available for eligible patients. A lot of progress has been made, with thousands of patients in receipt of a medical cannabis prescription, but there is still a lot of work to do
We are thrilled to announce that Curaleaf Clinic won ‘Cannabis Clinic of the Year’ at the Business of Cannabis Awards. Curaleaf International picked up three more awards, including ‘European Cannabis Company of the Year‘. Registered with the Care Quality Commission in 2019, Curaleaf Clinic was the
We asked our team why they enjoyed working at Sapphire and what helping patients safely access medical cannabis means to them. Meet the team and find out more via About Us… The post Meet The Team appeared first on Sapphire Medical Clinics.
What is the Care Quality Commission (CQC)? The Care Quality Commission (CQC) is the UK’s independent regulator of health and social care services. It exists to ensure that clinics, hospitals, and other healthcare providers are following all relevant guidelines and meet essential standards of safety, effectiveness,
In recent years, a number of cannabis-based medicinal products have been investigated for their potential in treating symptoms associated with Multiple Sclerosis (MS). Multiple sclerosis is a chronic condition of the nervous system affecting no two patients the same. Common features include visual disturbances, muscle weakness,
Copyright © 2020 – 2025 | The Cannabis Pages | All Rights Reserved | Important Notice | The Cannabis Pages “TCP” is an information resource for medical cannabis patients and prescribers. Nothing on the site should be construed as a promotion or inducement. TCP does not promote any product or represent that the products mentioned on TCP’s website are treatment for any kind of medical condition. TCP cannot guarantee that information provided is error-free or complete and is not responsible for the quality of the information provided by users. Cannabis is an unlicensed medication which can only be administered under the supervision of a licensed physician.
